← Open Payments lookup

HANLING ZHENG: Open Payments

NPI 1730847062 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$434 in 18 payments from 7 companies in 2025. Trend: 2023 $76 · 2024 $44 · 2025 $434

Food & beverage: $434
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.5$111
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$86
Janssen Pharmaceuticals, Inc2$80
Alkermes, Inc.3$58
ABBVIE INC.3$52
E.R. Squibb & Sons, L.L.C.1$26
Takeda Pharmaceuticals U.S.A., Inc.1$21

Products named: CAPLYTA, INVEGA SUSTENNA, REXULTI, VRAYLAR, ARISTADA, ABILIFY ASIMTUFII, COBENFY, TRINTELLIX.

Industry payments across PA — which companies pay providers there.